Gemina Laboratories Ltd. (GLABF)
Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections. The company maintains its corporate headquarters in Vancouver, Canada.
Industry: Biotechnology
Gemina Laboratories Ltd.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 76.57M shares outstanding
CAGemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions.
The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections.
The company maintains its corporate headquarters in Vancouver, Canada.
Leadership
Robert Crandall Greene
Chief Executive Officer & Director
Christine Buerki
Head of Research & Development
John F. Prins
Chief Financial Officer
Employees
--
Country
CA
Sector
Healthcare
Website
geminalabs.com
based on 76.57M shares outstanding
CA30d Avg
--
60d Avg
--
90d Avg
--